N.J. Laping
Department of Renal and Urology Research
GlaxoSmithKline Pharmaceuticals
King of Prussia
Pennsylvania 19406
USA
Name/email consistency: high
- Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Laping, N.J., Grygielko, E., Mathur, A., Butter, S., Bomberger, J., Tweed, C., Martin, W., Fornwald, J., Lehr, R., Harling, J., Gaster, L., Callahan, J.F., Olson, B.A. Mol. Pharmacol. (2002)
- Identification of a novel nuclear guanosine triphosphate-binding protein differentially expressed in renal disease. Laping, N.J., Olson, B.A., Zhu, Y. J. Am. Soc. Nephrol. (2001)
- Therapeutic uses of smad protein inhibitors: Selective inhibition of specific TGF-beta activities. Laping, N.J. IDrugs (1999)